Reversible interconversion and maintenance of mammary epithelial cell characteristics by the ligand-regulated EGFR system

Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871–890 (2009).

Nieto, M. A. Epithelial plasticity: a common theme in embryonic and cancer cells. Science 342, 1234850 (2013).

Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S. & Yang, J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725–736 (2012).

Ocana, O. H. et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22, 709–724 (2012).

Heldin, C. H., Vanlandewijck, M. & Moustakas, A. Regulation of EMT by TGFbeta in cancer. FEBS Lett 586, 1959–1970 (2012).

Burk, U. et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9, 582–589 (2008).

Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10, 593–601 (2008).

Gregory, P. A. et al. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell 22, 1686–1698 (2011).

Macara, I. G., Guyer, R., Richardson, G., Huo, Y. & Ahmed, S. M. Epithelial homeostasis. Curr Biol 24, R815–825 (2014).

Higashiyama, S. et al. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci 99, 214–220 (2008).

Citri, A. & Yarden, Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7, 505–516 (2006).

Ciarloni, L., Mallepell, S. & Brisken, C. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc Natl Acad Sci U S A 104, 5455–5460 (2007).

Luetteke, N. C. et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126, 2739–2750 (1999).

Shoyab, M., Plowman, G. D., McDonald, V. L., Bradley, J. G. & Todaro, G. J. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 243, 1074–1076 (1989).

Shin, S., Dimitri, C. A., Yoon, S. O., Dowdle, W. & Blenis, J. ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol Cell 38, 114–127 (2010).

Doehn, U. et al. RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. Mol Cell 35, 511–522 (2009).

Isokane, M. et al. Plasma-membrane-anchored growth factor pro-amphiregulin binds A-type lamin and regulates global transcription. J Cell Sci 121, 3608–3618 (2008).

Nakayama, H. et al. Cell surface annexins regulate ADAM-mediated ectodomain shedding of proamphiregulin. Mol Biol Cell 23, 1964–1975 (2012).

Fukuda, S., Nishida-Fukuda, H., Nakayama, H., Inoue, H. & Higashiyama, S. Monoubiquitination of pro-amphiregulin regulates its endocytosis and ectodomain shedding. Biochem Biophys Res Commun 420, 315–320 (2012).

Nakayama, H. et al. Human antigen R-mediated mRNA stabilization is required for ultraviolet B-induced autoinduction of amphiregulin in keratinocytes. J Biol Chem 288, 10338–10348 (2013).

Hieda, M. et al. Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane. J Cell Biol 180, 763–769 (2008).

Nanba, D., Mammoto, A., Hashimoto, K. & Higashiyama, S. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF. J Cell Biol 163, 489–502 (2003).

Soule, H. D. et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50, 6075–6086 (1990).

Tait, L., Soule, H. D. & Russo, J. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res 50, 6087–6094 (1990).

Sarrio, D. et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68, 989–997 (2008).

Maeda, M., Johnson, K. R. & Wheelock, M. J. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci 118, 873–887 (2005).

Brown, K. A. et al. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res 6, R215–231 (2004).

Hosono, S. et al. E-cadherin is a WT1 target gene. J Biol Chem 275, 10943–10953 (2000).

Debnath, J., Muthuswamy, S. K. & Brugge, J. S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256–268 (2003).

Shackleton, M. et al. Generation of a functional mammary gland from a single stem cell. Nature 439, 84–88 (2006).

Stingl, J. et al. Purification and unique properties of mammary epithelial stem cells. Nature 439, 993–997 (2006).

Lim, E. et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15, 907–913 (2009).

Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100, 3983–3988 (2003).

Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715 (2008).

Chaffer, C. L. et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154, 61–74 (2013).

Liu, S. et al. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Reports 2, 78–91 (2014).

Vidi, P. A., Bissell, M. J. & Lelievre, S. A. Three-dimensional culture of human breast epithelial cells: the how and the why. Methods Mol Biol 945, 193–219 (2013).

Haglund, K. & Dikic, I. The role of ubiquitylation in receptor endocytosis and endosomal sorting. J Cell Sci 125, 265–275 (2012).

Roepstorff, K. et al. Differential effects of EGFR ligands on endocytic sorting of the receptor. Traffic 10, 1115–1127 (2009).

Stern, K. A., Place, T. L. & Lill, N. L. EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate. Biochem J 410, 585–594 (2008).

Willmarth, N. E. et al. Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop. Cell Signal 21, 212–219 (2009).

Takeichi, M. Dynamic contacts: rearranging adherens junctions to drive epithelial remodelling. Nat Rev Mol Cell Biol 15, 397–410 (2014).

Zavadil, J. & Bottinger, E. P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24, 5764–5774 (2005).

Caramel, J. et al. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 24, 466–480 (2013).

Basbous, J., Chalbos, D., Hipskind, R., Jariel-Encontre, I. & Piechaczyk, M. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer. Mol Cell Biol 27, 3936–3950 (2007).

Murphy, L. O., Smith, S., Chen, R. H., Fingar, D. C. & Blenis, J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4, 556–564 (2002).

Torii, S., Kusakabe, M., Yamamoto, T., Maekawa, M. & Nishida, E. Sef is a spatial regulator for Ras/MAP kinase signaling. Dev Cell 7, 33–44 (2004).

Pasic, L. et al. Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue. Genes Dev 25, 1641–1653 (2011).

Mukhopadhyay, C., Zhao, X., Maroni, D., Band, V. & Naramura, M. Distinct effects of EGFR ligands on human mammary epithelial cell differentiation. PLoS One 8, e75907 (2013).

Vaudry, D., Stork, P. J., Lazarovici, P. & Eiden, L. E. Signaling pathways for PC12 cell differentiation: making the right connections. Science 296, 1648–1649 (2002).

Andreu-Perez, P. et al. Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF. Sci Signal 4, ra58 (2011).

Sigismund, S. et al. Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev Cell 15, 209–219 (2008).

Goh, L. K., Huang, F., Kim, W., Gygi, S. & Sorkin, A. Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor. J Cell Biol 189, 871–883 (2010).

Schroeder, J. A. & Lee, D. C. Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ 9, 451–464 (1998).

Mann, G. B. et al. Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair and curly whiskers and often develop corneal inflammation. Cell 73, 249–261 (1993).

Iwamoto, R. et al. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci USA 100, 3221–3226 (2003).

Shirasawa, S. et al. Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage. Proc Natl Acad Sci USA 101, 13921–13926 (2004).

Lee, S. et al. Alterations of gene expression in the development of early hyperplastic precursors of breast cancer. Am J Pathol 171, 252–262 (2007).

Berasain, C. & Avila, M. A. & Amphiregulin . Semin Cell Dev Biol 28, 31–41 (2014).

Busser, B., Sancey, L., Brambilla, E., Coll, J. L. & Hurbin, A. The multiple roles of amphiregulin in human cancer. Biochim Biophys Acta 1816, 119–131 (2011).

Chua, K. N. et al. A cell-based small molecule screening method for identifying inhibitors of epithelial-mesenchymal transition in carcinoma. PLoS One 7, e33183 (2012).

Albeck, J. G., Mills, G. B. & Brugge, J. S. Frequency-modulated pulses of ERK activity transmit quantitative proliferation signals. Mol Cell 49, 249–261 (2013).

Bollag, G. et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 467, 596–599 (2010).

Miyoshi, H., Blomer, U., Takahashi, M., Gage, F. H. & Verma, I. M. Development of a self-inactivating lentivirus vector. J Virol 72, 8150–8157 (1998).

Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 9, 676–682 (2012).

Kubota, H. et al. Temporal coding of insulin action through multiplexing of the AKT pathway. Mol Cell 46, 820–832 (2012).